Sarah is living with a urea cycle disorder
We care about rare disease patients
Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families.
- We have a diversified and growth-oriented commercial product portfolio.
- Key therapeutic areas are Inflammation and Genetics & Metabolism.
- Our late stage pipeline includes three phase III programs with substantial potential.
- We have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners.
Our sales and marketing organization covers about 20 countries in Europe and a subsidiary in the US. We are also represented through partners in in the Middle East, Australia and New Zealand.